Terms: = Endocrine gland cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Treatment
32 results:
1. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS).
Heidenreich A; Paffenholz P; Hartmann F; Seelemeyer F; Pfister D
Eur Urol Oncol; 2024 Feb; 7(1):122-127. PubMed ID: 37438222
[TBL] [Abstract] [Full Text] [Related]
2. Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis.
Torun BC; Glehen O; Kepenekian V; Sardi A; Arjona-Sanchez A; Yonemura Y; Barat S; Morris D; Spiliotis J; Coccolini F; Sommariva A; Bartos A; Raza S; Speteen KV; Akin L; Irez T; Canbay E;
Eur J Surg Oncol; 2023 Aug; 49(8):1489-1494. PubMed ID: 37085403
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations.
Yao H; Li N; Yuan H
BMC Cancer; 2022 Dec; 22(1):1337. PubMed ID: 36544182
[TBL] [Abstract] [Full Text] [Related]
4. Low-grade serous carcinoma detected from intraoperative peritoneal washings: Cytological findings and detection of KRAS mutation.
Yamamoto E; Warigaya K; Kinoshita Y; Yamamoto A; Murata SI
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1676. PubMed ID: 35801373
[TBL] [Abstract] [Full Text] [Related]
5. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.
Amintas S; Fernandez B; Chauvet A; Chiche L; Laurent C; Belleannée G; Marty M; Buscail E; Dabernat S
Sci Rep; 2022 Feb; 12(1):2976. PubMed ID: 35194118
[TBL] [Abstract] [Full Text] [Related]
6. Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H
BMC Cancer; 2021 Dec; 21(1):1319. PubMed ID: 34886831
[TBL] [Abstract] [Full Text] [Related]
7. Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound.
Kataoka K; Ishikawa T; Ohno E; Mizutani Y; Iida T; Ishikawa E; Furukawa K; Nakamura M; Honda T; Ishigami M; Kawashima H; Hirooka Y; Fujishiro M
Pancreatology; 2021 Oct; 21(7):1364-1370. PubMed ID: 34281790
[TBL] [Abstract] [Full Text] [Related]
8. The Value of Preoperative and Intraoperative Ultrasound in the Localization of Intrathyroidal Parathyroid Adenomas.
Zhao W; Lu R; Yin L; Wei B; Jin M; Zhang C; Guo R; Lv X
J Invest Surg; 2022 Apr; 35(4):752-757. PubMed ID: 34167410
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.
Shimatsu A; Nakamura A; Takahashi Y; Fujio S; Satoh F; Tahara S; Nishioka H; Takano K; Yamashita M; Arima H; Tominaga A; Tateishi S; Matsushita Y
Endocr J; 2021 Jul; 68(7):791-805. PubMed ID: 33692246
[TBL] [Abstract] [Full Text] [Related]
10. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
Coleridge SL; Bryant A; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD005343. PubMed ID: 33543776
[TBL] [Abstract] [Full Text] [Related]
11. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis.
Luo X; Yu B; Jiang N; Du Q; Ye X; Li H; Wang WQ; Zhai Q
Cancer Control; 2020; 27(1):1073274820977135. PubMed ID: 33269614
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
Grant RC; Denroche R; Jang GH; Nowak KM; Zhang A; Borgida A; Holter S; Topham JT; Wilson J; Dodd A; Jang R; Prince R; Karasinska JM; Schaeffer DF; Wang Y; Zogopoulos G; Berry S; Simeone D; Renouf DJ; Notta F; O'Kane G; Knox J; Fischer S; Gallinger S
Gut; 2021 Oct; 70(10):1894-1903. PubMed ID: 32933947
[TBL] [Abstract] [Full Text] [Related]
13. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
Coleridge SL; Bryant A; Lyons TJ; Goodall RJ; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684686
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic role of chemotherapy-induced nausea and vomiting in recurrent ovarian cancer patients: results of an individual participant data meta-analysis in 1213.
Woopen H; Richter R; Chekerov R; Inci G; Alavi S; Grabowski JP; Sehouli J
Support Care Cancer; 2020 Jan; 28(1):73-78. PubMed ID: 30980260
[TBL] [Abstract] [Full Text] [Related]
15. Effect of perithyroidal lignocaine infusion (PLI) to pain experienced during high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules.
Lang BHH; Woo YC; Chiu KW
Eur Radiol; 2019 Oct; 29(10):5280-5287. PubMed ID: 30919068
[TBL] [Abstract] [Full Text] [Related]
16. KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study.
Nakano Y; Kitago M; Matsuda S; Nakamura Y; Fujita Y; Imai S; Shinoda M; Yagi H; Abe Y; Hibi T; Fujii-Nishimura Y; Takeuchi A; Endo Y; Itano O; Kitagawa Y
Br J Cancer; 2018 Mar; 118(5):662-669. PubMed ID: 29360815
[TBL] [Abstract] [Full Text] [Related]
17. Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research.
Baechmann S; Ormanns S; Haas M; Kruger S; Remold A; Modest DP; Kirchner T; Jung A; Werner J; Heinemann V; Boeck S
BMC Cancer; 2017 May; 17(1):374. PubMed ID: 28549417
[TBL] [Abstract] [Full Text] [Related]
18. The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer.
Woopen H; Richter R; Ismaeel F; Chekerov R; Roots I; Siepmann T; Sehouli J
Gynecol Oncol; 2016 Mar; 140(3):554-8. PubMed ID: 26790772
[TBL] [Abstract] [Full Text] [Related]
19. The influence of comorbidity and comedication on grade III/IV toxicity and prior discontinuation of chemotherapy in recurrent ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO).
Woopen H; Richter R; Chekerov R; Siepmann T; Ismaeel F; Sehouli J
Gynecol Oncol; 2015 Sep; 138(3):735-40. PubMed ID: 26185017
[TBL] [Abstract] [Full Text] [Related]
20. Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets.
Wu H; Sun Y; Ye H; Yang S; Lee SL; de las Morenas A
Pathol Oncol Res; 2015 Jul; 21(3):695-701. PubMed ID: 25588542
[TBL] [Abstract] [Full Text] [Related]
[Next]
